Pot Stock Alert: This Company Just Spiked 146%

Pot stocks have been a roller coaster ride this year. At the start of 2020, cannabis companies were hit hard by the coronavirus correction. These pressures came after the terrible marijuana bear market of 2019, which saw industry valuations cut in half. Recent weeks, however, have brought much-needed relief. Indeed, some companies are seeing their share prices soar. One of…

Read More

Should Canadians Buy Aphria (TSX:APHA) Stock Today?

The coronavirus market crash is far from over yet. Non-essential sectors now face even brisker headwinds than previously was the case. This is especially the case in an overcrowded and unsettled space like cannabis. The move by the Ontario government to strike the sector from the “essentials” list was disheartening. But for some pot stocks, it could even have proved…

Read More

Why Did HEXO’s Stock Price Fall 26% on Wednesday?

Canadian marijuana producer HEXO‘s (TSX:HEXO)(NYSE:HEXO) stock price fell more than 26% on Wednesday as investors reacted to a news release the company issued that morning. What happened? HEXO announced a $40 million underwritten public offering of its common stock early on Wednesday. The latest offering was priced at $0.77 per share. This is a 20% discount to the previous day’s closing…

Read More

Molson Coors (TSX:TPX.B) Might Buy This Cannabis Stock in 2020

Molson Coors Canada (TSX:TPX.B)(NYSE:TAP) is one of Canada’s most iconic companies. It’s known as a beer stock, but the company could transform into a cannabis stock with a well-timed acquisition in 2020. Molson Coors was formed in 2005 by the merger of Molson of Canada and Coors of the United States, making it the world’s seventh-largest brewer. But its roots…

Read More

Why Canopy Growth Is Still the Best Pot Stock

Many times, one might later realize, size really does matter. In the case of Canada’s cannabis sector, Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) is the 800-pound gorilla in the room, which has helped stabilize the company’s valuation relative to its peers recently. Shares of Canopy are down significantly from their peak. However, Canopy shares haven’t decreased in the 80%-90% range like many…

Read More

Is MedMen Stock a Buy After Announcing a Change in Leadership?

It’s not often that you see a stock get a boost in value because its CEO leaves the company, but that’s what happened with MedMen Enterprises (CNSX:MMEN) stock. On Friday, the company announced that CEO and co-founder Adam Bierman would be stepping down and would no longer at the helm as of February 1. Shares of the struggling stock rose…

Read More

Why Did Aurora Cannabis (TSX:ACB) Stock Lose $12 Billion in Value?

Aurora Cannabis (TSX:ACB)(NYSE:ACB) was once the hottest cannabis stock in the world. In 2016, shares tripled. In 2017, they quadrupled. In 2018, the stock hit a high of $14, when just a few years prior, it was valued at $0.50. Last year, everything changed. The bear market of 2019 may ultimately go down as one of the most painful periods in…

Read More

Rich Stock, Poor Stock: The Tale of 2 Stocks in 2019

The Toronto Stock Exchange (TSX) reached an all-time high of 17,230.58 in December of 2019. There were winners, like AltaGas Canada (TSX:ACI), and a handful of losers that includes Hexo (TSX:HEXO)(NYSE:HEXO). The two companies have contrasting turnouts last year that merit investor attention. Rich stock With its steady performance last year, you can say that AltaGas Canada is one of 2019’s…

Read More

Why Did Canopy Growth (TSX:WEED) Stock Gain Almost 20% Yesterday?

Shares of Canada’s top cannabis company, Canopy Growth (TSX:WEED)(NYSE:CGC) rose close to 20% on November 20, 2019. The stock lost 33% in market value between November 8 and November 18, as the company reported underwhelming September-quarter results. Canopy disappointed investors with less-than-estimated revenue and earnings. Poor earnings of several other cannabis companies resulted in mayhem in the last week. Canopy…

Read More

Will Cronos (TSX:CRON) Stock Move Higher After a 25% Decline Last Week?

Shares of leading cannabis company Cronos Group (TSX:CRON)(NASDAQ:CRON) fell over 25% in the last week. Why did Cronos Group investors lose a quarter of their market value in the week ended on November 15, 2019? Cronos Group announced its third-quarter results on November 12 and reported sales of $12.7 million — 238% higher compared to sales of $3.76 million in…

Read More